Watch CBS News

Vaccine

cbsn-fusion-big-pharma-pharmaceutical-companies-covid-19-vaccine-thumbnail-611336-640x360.jpg

Could Big Pharma cash in on COVID vaccine?

Pfizer and Moderna could be looking at a big check once their first round of COVID vaccines are distributed, despite a non-lucrative market and pressure to keep costs low. But the key for both companies may lie in the patenting process. Quartz reporter Annalisa Merelli joined CBSN AM to explain how the COVID vaccine compares to other vaccines on the market and why the mRNA patent could have larger implications outside of coronavirus. She also gave insight to life inside Bergamo, Italy, one of the hardest-hit town earlier on in the pandemic.

cbsn-fusion-moderna-vaccine-next-in-line-for-fda-authorization-thumbnail-610556-640x360.jpg

FDA panel to discuss Moderna vaccine Thursday

The U.S. could be days away from authorizing a second coronavirus vaccine as both coasts see cases surge. CBS News correspondent David Begnaud reports on California hospitals grappling with a rising infection rate and Dr. Neeta Ogden, internal medicine specialist and immunologist, joined CBSN to discuss the how some states are struggling with vaccine funding and the Food and Drug Administration's authorization of the first over-the-counter rapid test.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue